Regulatory RNAs exert their cellular functions through RNA-binding proteins (RBPs). Identifying RNA-protein interactions is therefore key for a molecular understanding of regulatory RNAs. To date, RNA-bound proteins have been identified primarily through RNA purification followed by mass spectrometry. Here, we develop incPRINT (in cell protein-RNA interaction), a high-throughput method to identify in-cell RNA-protein interactions revealed by quantifiable luminescence. Applying incPRINT to long noncoding RNAs (lncRNAs), we identify RBPs specifically interacting with the lncRNA Firre and three functionally distinct regions of the lncRNA Xist. incPRINT confirms previously known lncRNA-protein interactions and identifies additional interactions that had evaded detection with other approaches. Importantly, the majority of the incPRINT-defined interactions are specific to individual functional regions of the large Xist transcript. Thus, we present an RNA-centric method that enables reliable identification of RNA-region-specific RBPs and is applicable to any RNA of interest.
The identification of RNA–protein interactions is essential for deciphering the cellular functions and molecular mechanisms of regulatory RNAs that act through the formation of dynamic ribonucleoprotein (RNP) complexes1. There are several established protein-centric approaches such as cross-linking immunoprecipitation (CLIP) methods that reliably and systematically identify all transcripts bound by individual proteins of interest2. By contrast, when the aim is to determine the proteomes bound by individual transcripts, RNA-centric approaches are applied, which are mainly based on affinity capture of an RNA of interest followed by mass-spectrometry (MS) identification of the co-purified proteins3. These powerful methods have led to the identification of a number of functionally relevant RNA–protein interactions. Nevertheless, the unbiased identification of RNA-bound proteomes following probe-based RNA immunoprecipitation often remains challenging due to the generally low efficiency of RNA affinity purifications requiring scaling up of the starting cellular material. When applied to RNAs expressed at the low copy numbers characteristic of many lncRNAs4, generating sufficient input material for RNA affinity capture-MS is difficult and presents a risk of contamination by nonspecific RBPs. In addition, RBPs that are expressed at relatively low levels often do not reach the threshold required for their robust detection by mass spectrometry. Furthermore, nearly all currently available approaches enable the identification of proteins binding the full-length transcript of interest, whereas many lncRNAs have a modular organization with discrete RNA regions performing different functions1,5. While dChIRP based on RNA affinity capture-MS has allowed validation of already known RNA-region-specific protein interactions6, the de novo identification and assignment of RBPs bound to distinct RNA regions requires dedicated approaches including comparative RNA affinity capture-MS performed on a mutant variant of the RNA of interest7 or precise mapping of the individual RBP binding by protein-centric CLIP methods8,9.
Given the growing repertoire of RNAs with important biological functions and the experimental challenges inherent in dissecting their molecular mechanisms of action, complementary strategies could prove helpful for defining the protein interactions of individual RNAs. Here, we present incPRINT, an alternative RNA-centric method to facilitate the in-cell identification and measurement of RNA–protein interactions. One of the distinguishing features of incPRINT is that it does not utilize direct RNA affinity capture, but is rather based on high-throughput immunoprecipitation of thousands of RBPs followed by luciferase-based detection of their interactions with the RNA of interest. Applying incPRINT to well-studied lncRNAs as a proof-of-principle demonstrates that incPRINT enables the identification of proteins interacting with RNAs expressed at low endogenous levels as well as proteins interacting with distinct regions of RNA, facilitating the assignment of RNA-interaction domains. We thus introduce incPRINT as a reliable method to identify in-cell RNA-interacting proteomes.
The incPRINT method to identify RNA–protein complexes
To identify RNA–protein interactions systematically in living cells, we developed a method that measures the cellular interactions between any tagged test RNA and any tagged test protein. The principle of incPRINT is the transient dual expression of a MS2-tagged test RNA and a FLAG-tagged test protein in HEK293T cells stably expressing a luciferase detector fused to the MS2 coat protein (MS2CP) from a genomically integrated plasmid (Fig. 1). The test RNA is tethered to the luciferase detector through the MS2-MS2CP interaction; the RNA-luciferase complex is co-purified with the FLAG-tagged test protein immunoprecipitated from cell lysates by anti-FLAG antibody (Fig. 1). Indirect RNA–protein interactions bridged by DNA are eliminated by DNase treatment after the cell lysis step. To detect each RNA–protein interaction, RNA-MS2 co-purified with the test FLAG-tagged protein is measured by quantifiable luciferase luminescence (Fig. 1). To control for test protein expression levels, the abundance of the test proteins is measured by ELISA using a second anti-FLAG antibody coupled to horseradish peroxidase (HRP) (Fig. 1). The incPRINT method is flexible in scale, usable as a low- or high-throughput assay. To enable systematic, high-throughput identification of cellular RNA–protein interactions, we generated a customized library of ∼3000 human FLAG-tagged proteins including ∼1500 known RBPs (based on refs. 10,11), ∼1300 transcription factors12, and ∼170 chromatin-associated proteins. The tagged protein content can be adapted to fit the desired experimental setup.
incPRINT reliably detects cellular RNA–protein interactions
To establish incPRINT, we performed a series of small-scale experiments using a ∼1-kb conserved region of the lncRNA Xist called the A repeat, hereafter referred to as Xist(A)13. Because several Xist(A)-protein interactions have been well established7, they served as controls in our initial incPRINT experiments. We engineered a construct to express Xist(A)-MS2 and assayed the ability of Xist(A)-MS2 RNA to interact with a selected set of previously identified Xist-binding proteins7,14,15. The non-discriminatory poly(A)-binding protein PABPC3 was used to control for RNA expression and EGFP (Enhanced Green Fluorescent Protein) was used as a negative control. incPRINT luminescence detected specific interactions of Xist(A)-MS2 with SPEN, RBM15, RBM15B, YTHDC1, HNRNPC, SRSF7, and RALY, whereas HNRNPU, reported to bind full-length Xist but not specifically Xist(A)7, and EGFP showed basal binding (Fig. 2a). The treatment with RNase abolished the RNA–protein interaction signal measured by luciferase, while the expression of test proteins detected by ELISA remained mostly unchanged (Fig. 2a, Supplementary Fig. 1a), demonstrating that the interactions between the tagged proteins and the luciferase detector were bridged by RNA.
To optimize the number of MS2 stem loops used to tag the tested RNA, Xist(A) was fused with two, four, six, ten or 24 MS2 stem loops, and their interactions with a set of control proteins were tested in a small-scale incPRINT experiment. An increase in the luminescence intensity directly correlated with an increased number of MS2 stem loops up to ten stem loops with no marked increase in binding to the EGFP control (Supplementary Fig. 1b). Therefore, in all subsequent incPRINT experiments, the RNAs were tagged with ten MS2 stem loops.
To determine whether the RNA–protein interactions detected by incPRINT indeed occurred in cells or arose only in vitro after cell lysis16,17,18, the luminescence signal from two independent experiments was measured and compared. In the first experiment, Xist(A)-MS2 RNA and FLAG-tagged test proteins were co-transfected in the same cell population as described above. In the second experiment, Xist(A)-MS2 RNA and FLAG-tagged test proteins were transfected separately in two different cell populations and pooled together only after the cell lysis step, permitting the formation of RNA–protein complexes exclusively in vitro (Supplementary Fig. 1c). We found that interactions were preferentially detected when Xist(A)-MS2 RNA and the FLAG-tagged proteins were co-transfected (the standard incPRINT condition; Fig. 2b). These results suggest that whenever an interaction signal was detected by incPRINT, it stemmed from the RNA–protein complexes formed in cells, whereas association of RNA–protein complexes post-cell lysis appeared as negligible background under incPRINT-specific conditions (Fig. 2b). Taken together, these experiments establish that incPRINT measures cellular RNA–protein interactions using a luminescence readout.
High-throughput detection of RNA–protein interactions
To test the scalability of incPRINT for systematic identification of RNA–protein interactions, we interrogated our customized library of ~3000 FLAG-tagged human proteins (including ∼1500 known RBPs10,11, ∼1300 transcription factors12, and ∼170 chromatin-associated proteins), with Xist(A)-MS2. To strengthen the confidence of the incPRINT-identified RNA–protein interactions, all interactions were assayed in biological duplicate, generating two luminescence (RNA–protein interaction intensity) and two ELISA (test protein expression level) values for each tested RNA–protein couple. After filtering out the proteins expressed at insufficient levels (see the ‘Methods’ section), interaction data were analyzed for 2405 proteins. incPRINT’s reproducibility was assessed by calculating the correlation scores of biological duplicates for both the luminescence (Fig. 2c; R2 = 0.87) and ELISA signals (Fig. 2d; R2 = 0.99). Notably, no correlation between luminescence and ELISA values was detected, indicating that the interaction intensities were not a mere reflection of the protein expression levels (Fig. 2e). In summary, our data demonstrate that incPRINT is a scalable high-throughput method that reproducibly measures RNA–protein interactions in cell.
incPRINT identifies proteome of lowly expressed RNAs
Next, we sought to test if incPRINT can robustly identify proteins interacting with transcripts expressed at low endogenous levels. Identification of proteins associated with low copy number RNAs is generally challenging when using RNA affinity capture-MS approaches due to the typically low efficiency of RNA purifications and the large amount of material required for mass spectrometry. Because Firre is a functionally important lncRNA that modulates higher-order nuclear architecture across chromosomes19 and is of a rather low endogenous abundance (∼20 molecules per cell based on RNA-Seq data across different mouse tissues), we assessed its RBP-interactome with incPRINT. The full-length Firre transcript tagged by MS2 was expressed ∼40-fold higher than endogenous FIRRE in the HEK293T cells used for incPRINT (Supplementary Fig. 2a). As reported for the endogenous transcript19, Firre-MS2 was preferentially localized to the nucleus (Supplementary Fig. 2b). Interrogating our library of ~3000 proteins, incPRINT identified a set of specific proteins as Firre interactors (Fig. 3a, red dots; Supplementary Data 1), whereas the majority of the proteins did not interact with Firre (Fig. 3a, gray dots; Supplementary Data 1). Importantly, incPRINT identified both known and novel Firre-interacting proteins. CTCF and HNRNPU, previously reported by two independent studies to bind Firre and to be important for its function19,20, were also identified by incPRINT (Fig. 3a). To validate binding of novel Firre interactors, we analyzed the ENCODE eCLIP data21. The eCLIP data, available for seven incPRINT-identified Firre-interacting RBPs, confirmed their binding to Firre in the K562 cell line, further validating the incPRINT method (Supplementary Fig. 2c; Supplementary Data 2). Consistent with the role of Firre in nuclear organization19, a set of Firre interactors identified by incPRINT were chromatin-associated proteins including CHD1, POU5F1, JARID2, EPC1, SATB1, MECP2, AEBP2, and CTCF (Supplementary Data 1). Protein domain analyses showed that Firre-interacting proteins were significantly enriched for the RNA recognition motif (RRM) (Fig. 3b; Supplementary Data 3).
To determine if RNA overexpression was required for incPRINT to successfully identify proteins binding to RNA with low endogenous levels, a set of proteins was tested with different concentrations of Firre-MS2 ranging from overexpression as described above to the levels comparable to endogenous FIRRE in HEK293T cells (Supplementary Fig. 2d, e). While RNA overexpression resulted in higher interaction scores enabling their better separation from the background scores, the luciferase signal was robustly detectable above background signal when dilutions of Firre-MS2 were used (Supplementary Fig. 2d). Importantly, this signal was not associated with the test protein expression levels (Supplementary Fig. 2e). Together, these data demonstrate the utility of incPRINT in identifying proteins associated with transcripts expressed at low endogenous levels.
incPRINT identifies RNA-region-specific interaction partners
Because many lncRNAs function as modular scaffolds, enabling binding of specific RBPs to discrete RNA domains1,5, we sought to test if incPRINT allows the identification of RNA-domain-specific interactions. An ideal proof-of-principle molecule is the lncRNA Xist, given its vital role in mammalian X-chromosome inactivation (XCI)22,23, and its modular structure and function. The ∼17-kb long Xist transcript contains several conserved sequence regions (called repeats A through F) that carry out distinct functions during the XCI process, including initiation of gene silencing (the A repeat), maintenance of the X-inactive state (the F- and B-repeats) and proper chromosomal localization and focal accumulation of Xist (the C- and E-repeats)13,24,25,26,27,28,29,30,31,32 (Fig. 4a). Moreover, several independent studies have previously identified and validated a set of functional protein interactions with full-length Xist7,14,15,26,28,33,34,35. We sought to apply incPRINT to three conserved regions of mouse Xist, i.e., Xist(A), Xist(F), and Xist(C) (Fig. 4a). When expressed in HEK293T cells used for incPRINT, each Xist-MS2 fragment showed a different level of expression compared to endogenous Xist, ranging from a ∼60-fold increase for Xist(A) to a near-endogenous expression level for Xist(C) (Supplementary Fig. 3a). All individual Xist-MS2 fragments were preferentially localized to the nucleus, similarly to their full-length endogenous counterpart (Supplementary Fig. 3b). Each Xist region (i.e., Xist(A), Xist(F), and Xist(C)) was interrogated with our library of ~3000 proteins. To compare signals across individual Xist regions expressed at different levels (Supplementary Fig. 3c), the interaction scores for each Xist region were normalized using the MS2 RNA binding data (Supplementary Data 4). For normalization, a set of 200 proteins with top ranking luciferase scores in the MS2 RNA dataset was defined as common binders of all MS2-tagged RNAs. The common binders were then identified in each dataset and their median interaction score was calculated for each tested RNA and used to normalize raw luminescence intensities in each dataset (see the ‘Methods’ section). Notably, MS2 data were not used as a binding specificity control, as many RBPs recognize low complexity RNA motifs36 present also within the MS2 tag, and since protein binding to MS2 does not exclude a potential functional interaction with a test RNA. Similarly to Firre, we found that the majority of proteins did not bind to any of the tested Xist fragments (Fig. 4b–d, gray dots; Supplementary Data 4), whereas specific sets of proteins were identified to interact with each individual Xist region (Fig. 4b–d, red dots; Supplementary Data 4). Importantly, among the incPRINT-identified Xist-interacting proteins, we found well-known interaction partners of Xist identified in previous studies to bind the full-length transcript7,14,15 (indicated in Fig. 4b–d, Supplementary Table 1). Comparing the sets of incPRINT-identified proteins and their interaction scores for each interrogated Xist region (Supplementary Data 4), we found that each Xist fragment interacted with a set of proteins specific to the corresponding region, with a minor fraction of RBPs binding to all three Xist regions (Fig. 4e). Thus, applying incPRINT to three conserved regions of Xist enabled the identification and assignment to specific RNA regions of RBPs previously determined to bind the full-length Xist transcript7,14,15 (Fig. 4e; known Xist-interacting proteins are indicated on the right). For example, incPRINT identified SPEN as a Xist(A)-specific interactor (Fig. 4e), confirming previous findings7,8. Similarly, RBM15, RBM15B and YTHDC1 were identified by incPRINT to interact specifically with Xist(A) and Xist(F), but not Xist(C), confirming their reported binding to the 5′ end of Xist7,9 (Fig. 4e). Moreover, we identified an Xist(C)-specific interaction with HNRNPU (also known as SAF-A) previously shown to be involved in Xist localization7,14,33 (Fig. 4e, Supplementary Table 1). To validate the RNA-region-specific Xist-protein interactions, the ENCODE eCLIP data21 available for 14 incPRINT-identified proteins, several of which are novel Xist-interacting RPBs, confirmed their binding to XIST in the K562 line (Supplementary Fig. 3d; Supplementary Data 2), further corroborating the specificity of our method. A functional difference among the protein interactomes of the three Xist regions was confirmed by Gene Ontology (GO) term enrichment analyses. Consistent with the differential functions reported for the individual Xist regions, Xist(A)- and Xist(F)-associated proteins were enriched for RBPs involved in RNA processing, while the C-repeat region preferentially interacted with DNA-binding proteins involved in transcriptional regulation (Supplementary Fig. 3e, f). In agreement with the GO analysis, the protein domain analysis demonstrated that Xist(A)-interacting proteins were enriched for the SPOC (Spen paralog and ortholog C-terminal) and RRM protein domains, Xist(F)-interacting proteins were enriched for the RRM domain and Xist(C)-interacting proteins showed no particular enrichment (Fig. 4f; Supplementary Data 3), further highlighting the specificity of incPRINT-identified protein sets for each Xist region. In summary, incPRINT successfully retrieved known Xist-protein interactions and uncovered novel RBPs. By identifying specific sets of proteins interacting with individual conserved regions of a modular lncRNA, we have demonstrated that incPRINT enables the region-specific assignment of RNA–protein interactions.
incPRINT identifies functional RNA–protein interactions
Because Xist has a well-characterized cellular function in gene silencing during XCI, we sought to test if some of the Xist-protein interactions uncovered using incPRINT are functionally relevant. The focus was on the ZZZ3 protein, which interacts with all three tested Xist regions, and RBM6, which exhibits more specific binding to the Xist(A) and Xist(F) regions (Fig. 4e). First, we confirmed the interaction of Xist with RBM6 and ZZZ3 under endogenous conditions by testing Xist co-precipitation with both proteins in mouse embryonic stem (ES) cells. The proteins were HA-tagged in the polymorphic TX1072 ES cell line that enables doxycycline-induced Xist expression, triggering XCI in the absence of differentiation31,37,38,39. RNA immunoprecipitation (RIP) after doxycycline induction of Xist and UV-cross-linking of cells followed by qRT-PCR analyses identified a significant enrichment of the Xist transcript with RBM6 and ZZZ3 proteins, confirming their interaction in vivo (Fig. 5a, b). Notably, incPRINT also identified RBM6 as interacting with Firre. RIP qRT-PCR detected a specific interaction of Firre with RBM6 but not with ZZZ3, thus confirming the Firre-RBM6 binding under endogenous conditions and further validating our incPRINT results (Fig. 5a, b).
Next, to test if RBM6 and ZZZ3 have an impact on XCI, we used single-cell RNA fluorescent in situ hybridization (RNA FISH) to assess the expression of endogenous Lamp2, an X-linked gene that is normally silenced during XCI initiation40. Upon doxycycline-induced Xist expression, depletion of Rbm6, Zzz3, and positive control Spen (Supplementary Fig. 4a, b) led to reduced silencing of Lamp2, whereas its XCI-induced mono-allelic expression remained unaltered upon depletion of Thap7, which did not interact with Xist and was used as a negative control (Fig. 5c, d; Supplementary Fig. 4c; Supplementary Table 2). In the absence of Xist (-doxycycline conditions), Lamp2 expression remained unchanged upon depletion of the proteins above (Supplementary Fig. 4d; Supplementary Table 2). Importantly, the defects in X chromosome silencing were not triggered by altered expression of Xist/Tsix upon depletion of the individual proteins (Supplementary Fig. 4e). In summary, the identification of functionally important interactors among the incPRINT-identified RBPs demonstrates incPRINT’s potential for discovery.
Several methods have been developed to comprehensively define the RNA-binding protein repertoire of all cellular RNAs10,11,41,42,43,44,45. To identify the protein interactomes of individual RNAs of interest, we report here incPRINT, a reliable RNA-centric technology which we show uncovers both known and previously unknown RNA–protein interactions. incPRINT successfully overcomes two major obstacles in determining the proteomes of specific RNAs: first, incPRINT enables the identification of proteins associated with RNAs expressed at low endogenous levels, common for many lncRNAs and, second, incPRINT allows the detection of RNA-region-specific protein interactions and the assignment of protein binding to defined regions of a full-length transcript. This is particularly advantageous for defining the RNA-region-specific binding proteome of large modular RNAs with multiple functional regions, such as the ∼17-kb-long Xist transcript. While other RNA-centric methods such as dChIRP have allowed the validation of already known RNA-region-specific protein interactions6, incPRINT enables their de novo identification. Considering this feature of incPRINT, one could envision a higher-resolution mapping of RBP binding along a transcript of interest by applying a low- or medium-throughput-scale incPRINT to shorter RNA fragments or their mutated variants.
Several key aspects of incPRINT distinguish it from the RNA-centric methods currently employed for the identification of RNA–protein interactions. First, incPRINT does not rely on probe-based capture and direct RNA affinity purification, which generally exhibits a low efficiency and thus requires large amounts of material. Because it uses a sensitive luciferase detector, incPRINT is not limited by RNA low copy number and can be applied to any RNA of interest. Second, the quantitative nature of the luciferase detector used in incPRINT makes it suitable for various custom applications and offers the possibility of structure/function analyses of mutated or disordered RNA–protein interactions and their relative effects on binding affinities. Third, the ability of incPRINT to measure cellular RNA–protein interactions one by one, independently of the cell’s physiological state, is particularly relevant for defining RNA-bound proteomes of transcripts that display a dynamic expression range during development and/or cellular differentiation, as observed with Xist throughout different stages of XCI7. Finally, incPRINT is flexible in its throughput: we employed here a customized library of ~ 3000 human test proteins comprising together ~1/7 of the human proteome and representing the majority of all known RBPs, transcription factors and chromatin modifiers. Using this protein library, we discovered functional interactors that had evaded detection with other methods; however, the library can conveniently be expanded to include a range of additional proteins, or reduced and customized to fit the experimental design and need.
While incPRINT enables fast, systematic and quantitative identification of RNA–protein interactions, it is a binding assay that does not consider the developmental context or timing of these interactions. However, this potential limitation did not hinder the identification of Xist-protein interactions in a heterologous cell line. Because incPRINT is based on ectopic expression of the test protein and RNA components, it is possible that a fraction of the identified interactions will be false positives. While such interactions cannot be excluded, the number of highly specific interactors for each interrogated RNA corresponding to 2–3% of all screened proteins and the validation of a set of interactions by orthogonal methods suggest that the rate of false positive binding identified by incPRINT is rather low. Furthermore, whereas all interactions validated in this study were direct, the design of the method does not make it possible to distinguish between direct and indirect RNA–protein interactions and additional assays are required to stipulate direct RNA binding. In summary, applying the incPRINT method to other noncoding or coding RNAs of various structural complexities will facilitate the discovery of the precise mechanisms by which they exert their cellular functions through the identification of their binding proteins.
To generate the stable monoclonal HEK293T cell line (gift from the Raphael Margueron laboratory, Institut Curie) expressing NanoLuc-MS2CP fusion protein, the NanoLuc-MS2CP expression plasmid was transfected using polyethylenimine (PEI) followed by puromycin selection. The expression of NanoLuc-MS2CP was verified by measuring luciferase activity. The cells were maintained in DMEM (Gibco 12007559) containing 10% fetal bovine serum (Gibco 11573397) and 1% penicillin/streptomycin (Gibco 15140122).
The female hybrid mouse TX1072 ES cell line37 (Edith Heard laboratory, Institut Curie) that harbors a doxycycline-responsive promoter controlling Xist expression on the B6 X chromosome and was derived from a cross of a TX/TXR26rtTA/rtTA female38 with a male Mus musculus castaneus was used. ES cells were cultured in high-glucose DMEM (Sigma) supplemented with 15% fetal calf serum (Eurobio, S59341-1307), 0.1 mM β-mercaptoethanol, 1000 U/mL leukemia inhibitory factor (LIF, Chemicon), and 2i (3 μM GSK3 inhibitor CT-99021, and 1 μM MEK inhibitor PD0325901). Xist expression was induced with doxycycline (Sigma) for 24 h for RNA FISH analysis.
Generation of the HA-tagged RBM6 and ZZZ3 ES cell lines
The TX1072 ES cell line37 was used to generate HA-tagged RBM6 and ZZZ3 cell lines. The HA tag was introduced at the C-terminus of RBM6 and ZZZ3. The tag flanked by two ∼600 nt homology arms was cloned into a pBR322 vector. TX1072 ES cells were transfected using Lipofectamine 2000, with the RBM6 or ZZZ3 HA-targeting vectors together with the pX459 vector containing a gRNA sequence targeting each of the proteins, promoting homologous recombination. Transfected clones were selected with 0.4 μg/mL of puromycin. Clones were genotyped for integration at the correct genomic location by PCR and DNA sequencing to ensure no deletions or mutations in the protein-coding sequence. All relevant oligonucleotide sequences are listed in Supplementary Data 5.
Gene knockdown was achieved using esiRNAs46 (Eupheria Biotech) directed against Rbm6 and Zzz3, luciferase and Thap7 as negative controls and Spen as a positive control. esiRNA transfections into TX1072 ES cells were conducted using 0.1 μg esiRNAs and Lipofectamine 2000 Transfection Reagent (Thermo Fisher Scientific), in Optimem I reduced serum medium (Thermo Ficher Scientific). Doxycycline-mediated Xist expression was initiated 48 h post-transfection, and cells were harvested 24 h post-doxycycline induction of Xist. The same experimental setup was used for RNA-FISH, RT-qPCR and RIP experiments. To assess esiRNA knockdown efficiencies, 50 ng of total RNA were reverse-transcribed using the SuperScript IV kit (Invitrogen) followed by qPCR using SYBRgreen (Applied biosystems). Arppo mRNA was used to normalize RNA levels between samples. All relevant oligonucleotides are listed in Supplementary Data 5.
Generation of incPRINT expression constructs
To generate the luciferase-MS2CP expression vector, NanoLuc luciferase was amplified from the pNL1.1 plasmid (Promega) and cloned into the pCi-MS2 vector47 using PstI and BamHI restriction sites. A puromycin resistance gene was added to the plasmid using PvtI restriction site. To remove the FLAG tag present in the original plasmid, a stop codon was introduced between the MS2CP and the FLAG tag by site-directed mutagenesis (Agilent).
To generate customized RNA-10xMS2 constructs, the pCDNA3.1 plasmid (Thermo Fisher) was modified. First, additional restriction sites (BstBI, AgeI, ClaI, AscI, PacI, BglII, and SrfI) were incorporated between the KpnI and BamHI sites. Second, MS2 stem loops were inserted between the BamHI and BglII sites. Xist(A), (F), and (C) fragments were PCR-amplified from BAC 399K20 (covering chrX:100,578,985–100,773,006, mm9 genome assembly), and cloned upstream of the MS2 stem loops by Gibson assembly (New England Biolabs). Primers used for Xist fragments amplification and cloning are indicated in Supplementary Data 5.
Human FLAG-tagged protein library
The transcription factor collection has been previously described12. The collection of human RBPs and chromatin-associated proteins were cloned with Gateway recombination from the human ORFeome 5.1 (http://horfdb.dfci.harvard.edu/hv5/index.php) into a mammalian expression vector with a C-terminal 3xFLAG-V5 tag. The expression clones were verified by restriction enzyme digestion.
384-well plates (Greiner Bio-One 781074) were coated overnight with the anti-FLAG M2 antibody (F1804, Sigma; 10 μg/ml in 1x PBS) and blocked for two hours at room temperature in 1% BSA, 5% sucrose, 0.5% Tween 20 in 1x PBS. Plasmids encoding RNA-MS2 and 3xFLAG-tagged test proteins were co-transfected into a 293T stable cell line expressing the NanoLuc luciferase fused to MS2CP. The day before transfection, cells were seeded in 96-well plates (30,000 cells per well). Co-transfections were performed using 12 µg/ml (300 ng of each plasmid per well). To achieve different expression levels of Firre-MS2, 30 ng (1:10), and 6 ng (1:50) of the Firre-MS2 encoding vector were used for transfections. Two days after transfection, cells were washed twice with ice-cold 1x PBS and lysed in ice-cold RQ1-HENG buffer (20 mM HEPES-KOH [pH 7.9], 150 mM NaCl, 10 mM MgCl2, 1 mM CaCl2, 5% glycerol, 1% Triton X-100, supplemented with protease inhibitors) containing 30 U/ml of RQ1 DNase (Promega M6101). After lysis (10 min, 4 °C) and DNase incubation (30 min, 37 °C), the lysates were transferred to 384-well plates coated with anti-FLAG M2 antibody (F1804, Sigma; 10 μg/ml in 1x PBS). Following a three-hour incubation at 4 °C, plates were washed seven times with RQ1-HENG buffer. Furimazine substrate (Promega) was added to the plates and luminescence in each well was measured with a plate reader (Biotek Synergy Neo). Following luminescence measurement, HRP-conjugated anti-FLAG antibody (ab1238, Abcam) in ELISA buffer (1x PBS, 1% goat serum, 1% Tween 20) was added to each well. After 30 min of incubation at room temperature, plates were washed with 1x PBS, 0.05% Tween 20, HRP substrates (Pierce) were added and ELISA signals were detected with the plate reader. For the RNase treatment experiment, RNA–protein interactions were first measured as described above. Fifty microliters of RNase buffer containing 50 mM Tris-HCl pH 8.0, 10 mM EDTA, +/−100 μg/ml RNase A (Qiagen) were added to the samples and incubated for 30 min at 37 °C, followed by three washes with RQ1-HENG buffer, before proceeding with luminescence measurements. All 96- and 384-plate washes were performed with a plate washer (Biotek EL406).
incPRINT data analysis and normalization
For each studied RNA (i.e., Firre-MS2, Xist(A)-MS2, Xist(F)-MS2, Xist(C)-MS2), all FLAG-tagged proteins were tested in duplicates achieved by independent transfections. After measuring the NanoLuc and ELISA luminescence, log2-transformed ELISA values were binned to assess the distribution of the FLAG-tagged protein expression. Proteins with the lowest ELISA signals were filtered out (status 2 in Supplementary Data 1 and 4). Interaction values between a test RNA-MS2 and a test protein were defined as the average between the two luciferase luminescence replicates. To ensure the robustness of the interaction analysis, luciferase replicates that showed the highest discrepancy (average/s.d. <1.5, unless both duplicates showed a high interaction score) were removed from the dataset (status 3 in Supplementary Data 1 and 4).
To compare the interaction intensities among individual RNA-MS2 transcripts, raw luminescence intensities were normalized. A set of proteins exhibiting a luminescence signal with MS2 was defined as common binders, assumed to interact with all tested RNA-MS2 transcripts. For each tested RNA-MS2 transcript, the median interaction scores of this set of common binders was calculated and used to normalize all raw luminescence intensities measured for the corresponding RNA-MS2. The comparison between Xist(A)-MS2, Xist(F)-MS2, and Xist(C)-MS2 interactors, includes all test proteins showing interaction with at least one test RNA, and expressed in all three assays.
Protein domain analysis
A list of the Pfam domains of each protein was downloaded from the Ensembl site. Enrichment of each domain in the set of interactors of a particular RNA vs. the protein library was calculated using a proportion test.
Xist expression was induced in undifferentiated ES cells by addition of 1 μg/mL of doxycycline to the culture medium 48 h post-transfection. Twenty-four hours upon Xist induction, cells were harvested using TrypLE Express Enzyme (Thermo Fisher Scientific), washed with 1x PBS, and adsorbed onto Poly-L-Lysine (Sigma)-coated glass coverslips for 10 min. Fixation was performed with 3% paraformaldehyde for 10 min at room temperature, followed by permeabilization in 1x PBS containing 0.5% of Triton X-100 and 2 mM of vanadyl-ribonucleoside complex (New England Biolabs), for 5 min at 4 °C. Coverslips were washed three times in 70% ethanol, and preserved at −20 °C in 70% ethanol. Prior to hybridization, coverslips were dehydrated with increasing concentrations of ethanol (80%, 95%, 100% twice, 5 min each), and air-dried. Transcription of the X-linked gene Lamp2 was detected with a BAC spanning its genomic region (RP24-173A8). The Lamp2 probe was labeled with dUTP-Spectrum Green (Enzo, Life Sciences) by nick translation (Abbot). The probes were precipitated with ethanol, resuspended in formamide at 37 °C, denatured at 75 °C for 10 min, and competed with mouse Cot1 DNA (Thermo Fisher) for 1–2 h at 37 °C. Xist was detected with a dUTP-Spectrum Red (Enzo, Life Sciences) nick translation probe from a plasmid spanning its genomic region48. The Xist probe was prepared as described above for the Lamp2 probe, except for the competition step, which was not performed. Probes were mixed and co-hybridized in FISH hybridization buffer (50% formamide, 20% dextran sulfate, 2x SSC, 1 μg/μL BSA (New England Biolabs), 10 mM Vanadyl-ribonucleoside) overnight at 37 °C. Coverslips were washed 3 × 6 min in 50% formamide in 2x SSC, pH 7.2, at 42 °C, followed by two 5-min washes in 2x SSC at 42 °C. Nuclei were counterstained with 0.2 mg/mL of 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) in 2x SSC for 3 min at room temperature, and mounted onto glass slides using VectaShield mounting medium. Images were acquired using the wide-field DeltaVision Core microscope (Applied Precision) and the inverted confocal Spinning Disk Roper/Nikon-FRAP microscope. 3D image stacks were analyzed with ImageJ.
Western blot analysis
To assess knockdown efficiency at the protein level, TX1072 ES cells were transfected with 2.5 μg of esiRNAs for RLuc (as a negative control), Rbm6 and Zzz3. Whole cell extracts were prepared with RIPA buffer (50 mM Tris-HCl pH 8–8.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) with freshly added 1x protease inhibitor (Roche). Western blot analysis was performed with antibodies detecting RBM6 (HPA026272, Sigma; 1:250), ZZZ3 (SAB4501106, Sigma; 1:1000) and Tubulin (CP06 mouse monoclonal antibody (DM1A), Merck Millipore; 1:3000). Full blots are provided as a Source Data file.
RNA immunoprecipitation (RIP)
RIP experiments were performed using corresponding HA-tagged RBM6 and ZZZ3 TX1072 cell lines. Approximately 15 million cells were treated with doxycycline (1 µg/ml) for 16 h. Cells were washed once with ice-cold 1x PBS and UV-crosslinked using 800 mJ/cm2, at 254 nm (Stratalinker, Stratagene). Cells were then collected, pelleted and lysed for 10 min on ice in 200 µl of RIPA buffer containing protease inhibitors (Roche) and RNAsin (Invitrogen). Cell lysates were sonicated using a Bioruptor (Diagenode) (6 cycles; 15 s on, 30 s off), and centrifuged for 10 min at 15,000 × g. Supernatant were collected and diluted in RQ1-HENG buffer (to 1.2 ml). Fifty microliters of anti-HA bead slurry (Pierce, 88836) was washed twice with 1 ml of RQ1-HENG buffer and incubated with the cell lysate for 2 h at 4 °C. Following the incubation, beads were washed twice with TNM600 buffer (50 mM Tris-HCl [pH 7.8], 0.6 M NaCl, 1.5 mM MgCl2, 0.1% NP40), and twice with TNM100 buffer (50 mM Tris-HCl [pH 7.8], 0.1 M NaCl, 1.5 mM MgCl2, 0.1% NP40). Elution was performed in 50 µl Laemmli buffer (2 min, 90 °C), RNA was extracted (Trizol-Chloroform) and treated with TURBO DNase (Ambion). Two hundred and fifty nanograms of RNA were reverse-transcribed using the SuperScript IV kit (Invitrogen) followed by qPCR using SYBRgreen (Applied biosystems). Gapdh was used as a reference gene to normalize RNA levels between samples. All relevant oligonucleotides are listed in Supplementary Data 5.
Nuclear/cytoplasmic fractionation and calculation of RNA expression
Two days after the RNA-MS2 transfections, HEK293T cells were centrifuged (5 min, 100 × g, 4 °C), washed with 1x PBS, resuspended in 100 μl of buffer A (10 mM HEPES pH 7.9, 5 mM MgCl2, 250 mM sucrose, protease inhibitors), incubated for 10 min on ice, and centrifuged again (10 min, 2350 × g, 4 °C). The supernatant was collected (cytosolic fraction), and the pellet was resuspended in 100 μl of buffer B (25 mM HEPES pH 7.9, 20% glycerol, 1.5 mM MgCl2, 0.1 mM EDTA, 0.7 M NaCl, protease inhibitors). After sonication (Bioruptor, Diagenode; 6 cycles; 15 s on, 30 s off) and centrifugation (21,000 × g, 15 min, 4 °C), the supernatant was collected (nuclear fraction). RNA was extracted from both fractions, and treated with Turbo DNase (Ambion). Hundred nanograms of RNA were reverse-transcribed using the SuperScript IV kit (Invitrogen) followed by qPCR analysis using SYBRgreen (Applied Biosystems). β-actin was used as a reference gene. Nuclear/cytoplasmic ratios were calculated for every tested transcript. All relevant oligonucleotides are listed in Supplementary Data 5.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
A reporting summary for this article is available as a Supplementary Information file. The source data underlying Fig. 5a, b and Supplementary Fig. 1b are provided as a Source Data file. All data generated and analyzed during this study are included in this article and its Supplementary Information file. All data is available from the corresponding author upon reasonable request.
Engreitz, J. M., Ollikainen, N. & Guttman, M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat. Rev. Mol. Cell Biol. 17, 756–770 (2016).
Konig, J., Zarnack, K., Luscombe, N. M. & Ule, J. Protein-RNA interactions: new genomic technologies and perspectives. Nat. Rev. Genet 13, 77–83 (2012).
Chu, C., Spitale, R. C. & Chang, H. Y. Technologies to probe functions and mechanisms of long noncoding RNAs. Nat. Struct. Mol. Biol. 22, 29–35 (2015).
Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).
Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339–346 (2012).
Quinn, J. J. et al. Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification. Nat. Biotechnol. 32, 933–940 (2014).
Chu, C. et al. Systematic discovery of Xist RNA binding proteins. Cell 161, 404–416 (2015).
Van Nostrand, E. L. et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat. Methods 13, 508–514 (2016).
Patil, D. P. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369–373 (2016).
Baltz, A. G. et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 46, 674–690 (2012).
Castello, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393–1406 (2012).
Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150, 987–1001 (2012).
Nesterova, T. B. et al. Characterization of the genomic Xist locus in rodents reveals conservation of overall gene structure and tandem repeats but rapid evolution of unique sequence. Genome Res. 11, 833–849 (2001).
McHugh, C. A. et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 521, 232–236 (2015).
Minajigi, A. et al. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science 349, https://doi.org/10.1126/science.aab2276 (2015).
McHugh, C. A., Russell, P. & Guttman, M. Methods for comprehensive experimental identification of RNA-protein interactions. Genome Biol. 15, 203 (2014).
Mili, S. & Steitz, J. A. Evidence for reassociation of RNA-binding proteins after cell lysis: implications for the interpretation of immunoprecipitation analyses. RNA 10, 1692–1694 (2004).
Riley, K. J., Yario, T. A. & Steitz, J. A. Association of Argonaute proteins and microRNAs can occur after cell lysis. RNA 18, 1581–1585 (2012).
Hacisuleyman, E. et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre. Nat. Struct. Mol. Biol. 21, 198–206 (2014).
Yang, F. et al. The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation. Genome Biol. 16, 52 (2015).
Van Nostrand, E. L. et al. A large-scale binding and functional map of human RNA binding proteins. bioRxiv, https://doi.org/10.1101/179648 (2017).
Borsani, G. et al. Characterization of a murine gene expressed from the inactive X chromosome. Nature 351, 325–329 (1991).
Brown, C. J. et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349, 38–44 (1991).
Almeida, M. et al. PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation. Science 356, 1081–1084 (2017).
Beletskii, A., Hong, Y. K., Pehrson, J., Egholm, M. & Strauss, W. M. PNA interference mapping demonstrates functional domains in the noncoding RNA Xist. Proc. Natl Acad. Sci. USA 98, 9215–9220 (2001).
da Rocha, S. T. et al. Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome. Mol. Cell 53, 301–316 (2014).
Ridings-Figueroa, R. et al. The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes Dev. 31, 876–888 (2017).
Sarma, K. et al. ATRX directs binding of PRC2 to Xist RNA and Polycomb targets. Cell 159, 869–883 (2014).
Senner, C. E. et al. Disruption of a conserved region of Xist exon 1 impairs Xist RNA localisation and X-linked gene silencing during random and imprinted X chromosome inactivation. Development 138, 1541–1550 (2011).
Sunwoo, H., Colognori, D., Froberg, J. E., Jeon, Y. & Lee, J. T. Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1). Proc. Natl Acad. Sci. USA 114, 10654–10659 (2017).
Wutz, A., Rasmussen, T. P. & Jaenisch, R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat. Genet 30, 167–174 (2002).
Sarma, K., Levasseur, P., Aristarkhov, A. & Lee, J. T. Locked nucleic acids (LNAs) reveal sequence requirements and kinetics of Xist RNA localization to the X chromosome. Proc. Natl Acad. Sci. USA 107, 22196–22201 (2010).
Hasegawa, Y. et al. The matrix protein hnRNP U is required for chromosomal localization of Xist RNA. Dev. Cell 19, 469–476 (2010).
Jeon, Y. & Lee, J. T. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 146, 119–133 (2011).
Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750–756 (2008).
Dominguez, D. et al. Sequence, structure, and context preferences of human RNA binding proteins. Mol. Cell 70, 854–867 e859 (2018).
Schulz, E. G. et al. The two active X chromosomes in female ESCs block exit from the pluripotent state by modulating the ESC signaling network. Cell Stem Cell 14, 203–216 (2014).
Savarese, F., Flahndorfer, K., Jaenisch, R., Busslinger, M. & Wutz, A. Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol. Cell Biol. 26, 7167–7177 (2006).
Zylicz, J. J. et al. The implication of early chromatin changes in X chromosome inactivation. Cell https://doi.org/10.1016/j.cell.2018.11.041 (2018).
Chaumeil, J., Le Baccon, P., Wutz, A. & Heard, E. A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev. 20, 2223–2237 (2006).
Queiroz, R. M. L. et al. Comprehensive identification of RNA-protein interactions in any organism using orthogonal organic phase separation (OOPS). Nat. Biotechnol. 37, 169–178 (2019).
Perez-Perri, J. I. et al. Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture. Nat. Commun. 9, 4408 (2018).
Kwon, S. C. et al. The RNA-binding protein repertoire of embryonic stem cells. Nat. Struct. Mol. Biol. 20, 1122–1130 (2013).
Caudron-Herger, M. et al. R-DeeP: proteome-wide and quantitative identification of RNA-dependent proteins by density gradient ultracentrifugation. Mol. Cell 75, 184–199 e110 (2019).
Treiber, T. et al. A compendium of RNA-binding proteins that regulate MicroRNA biogenesis. Mol. Cell 66, 270–284 (2017).
Kittler, R. et al. Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies. Nat. Methods 4, 337–344 (2007).
Chao, J. A., Patskovsky, Y., Almo, S. C. & Singer, R. H. Structural basis for the coevolution of a viral RNA-protein complex. Nat. Struct. Mol. Biol. 15, 103–105 (2008).
Chaumeil, J., Augui, S., Chow, J. C. & Heard, E. Combined immunofluorescence, RNA fluorescent in situ hybridization, and DNA fluorescent in situ hybridization to study chromatin changes, transcriptional activity, nuclear organization, and X-chromosome inactivation. Methods Mol. Biol. 463, 297–308 (2008).
We thank Ines Anna Drinnenberg, Raphael Margueron, Donal O’Carroll, and Dina Zielinski for comments on this paper. We also thank all members of the Shkumatava and Heard laboratories for stimulating discussions. This work was supported by grants from ERC (FLAME-337440), ATIP-Avenir, and La Fondation Bettencourt Schueller to A.S.; and by ERC (XPRESS-671027) and ANR (NoncodiX) to E.H. A.G. was supported by the ARC postdoctoral fellowship (20131200567), short-term EMBO (ESTF324-2015) and Company of Biologists travel (JCSTF-150421) fellowships, and LabEx DEEP (ANR-11-LABX-0044, ANR-10-IDEX-0001-02). I.P. was supported by the EMBO long-term fellowship (ALTF 549-2014), and Fondation pour la Recherche Medicale grant SPF 20140129387, A.N. was supported by the PSL-Biogen PhD fellowship. The imaging experiments were performed in the Cell and Tissue Imaging Facility/UMR3215 (PICT-IBiSA) of the Institut Curie, member of the French National Research Infrastructure France-BioImaging (ANR-10-INBS-04).
A.S. is an inventor on a pending patent application number PCT/EP2019/073999. Applicants: Institut Curie; INSERM (Institut National de la Santé et de la Recherche Médicale); CNRS (Centre National de la Recherche Scientifique). All other authors declare no competing interests.
Peer review information Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Graindorge, A., Pinheiro, I., Nawrocka, A. et al. In-cell identification and measurement of RNA-protein interactions. Nat Commun 10, 5317 (2019). https://doi.org/10.1038/s41467-019-13235-w
Nature Structural & Molecular Biology (2020)
Nature Communications (2020)
Molecular Genetics and Genomics (2020)